Chemours (CC) announced that the PCC Group plans to build and operate a chlor-alkali facility on the grounds of Chemours’ titanium dioxide, or TiO2, plant in DeLisle, Mississippi and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent. The new facility will utilize technology to maximize energy efficiency and provide up to an annual nameplate capacity of 340,000 metric tons once the plant is operational. The co-product, caustic soda, will be sold by PCC to strategic partners and on the open market. Construction is expected to begin in early 2026 with the plant being operational in 2028. The project will create full-time opportunities for skilled personnel with PCC, and up to 1,200 temporary construction jobs.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CC:
- Chemours Company Optimizes Loan Terms for Financial Strategy
- Chemours price target lowered to $25 from $30 at Morgan Stanley
- Chemours price target raised to $23 from $21 at Barclays
- Chemours Reports Q3 2024 Results and Strategic Update
- Chemours rises 14.7%
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
